Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William A Parsonage

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
BMJ Open|February 10, 2021
Cost-effectiveness analysis of percutaneous coronary intervention for single-vessel coronary artery disease: an economic evaluation of the ORBITA trialVictoria McCreanor, Alexandra Nowbar, Christopher Rajkumar, et al.
Emergency Medicine Journal : EMJ|January 20, 2016
Time to presentation and 12-month health outcomes in patients presenting to the emergency department with symptoms of possible acute coronary syndromeLouise Cullen, Jaimi H Greenslade, Louven Menzies, et al.
International Journal of Cardiology|April 16, 2013
Delta troponin for the early diagnosis of AMI in emergency patients with chest painLouise Cullen, William A Parsonage, Jaimi Greenslade, et al.
Emergency Medicine Australasia : EMA|December 11, 2012
Comparison of early biomarker strategies with the Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for risk stratification of emergency department patients with chest painLouise Cullen, William A Parsonage, Jaimi Greenslade, et al.
The American Journal of Emergency Medicine|May 25, 2013
Validation of the Vancouver Chest Pain Rule using troponin as the only biomarker: a prospective cohort studyJaimi H Greenslade, Louise Cullen, Martin Than, et al.
Heart (British Cardiac Society)|January 6, 2016
Sex-specific versus overall cut points for a high sensitivity troponin I assay in predicting 1-year outcomes in emergency patients presenting with chest painLouise Cullen, Jaimi H Greenslade, Edward W Carlton, et al.
Heart, Lung & Circulation|May 21, 2013
Comparison of three risk stratification rules for predicting patients with acute coronary syndrome presenting to an Australian emergency departmentLouise Cullen, Jaimi Greenslade, Christopher J Hammett, et al.
The American Journal of Emergency Medicine|November 19, 2013
The new Vancouver Chest Pain Rule using troponin as the only biomarker: an external validation studyLouise Cullen, Jaimi H Greenslade, Martin Than, et al.
The Medical Journal of Australia|February 18, 2014
Validation of an accelerated high-sensitivity troponin T assay protocol in an Australian cohort with chest painWilliam A Parsonage, Jaimi H Greenslade, Christopher J Hammett, et al.
Heart, Lung & Circulation|July 1, 2020
CSANZ Position Statement on the Evaluation of Patients Presenting With Suspected Acute Coronary Syndromes During the COVID-19 PandemicWilliam A Parsonage, Louise Cullen, David Brieger, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
BMJ Open|February 10, 2021
Cost-effectiveness analysis of percutaneous coronary intervention for single-vessel coronary artery disease: an economic evaluation of the ORBITA trialVictoria McCreanor, Alexandra Nowbar, Christopher Rajkumar, et al.
Emergency Medicine Journal : EMJ|January 20, 2016
Time to presentation and 12-month health outcomes in patients presenting to the emergency department with symptoms of possible acute coronary syndromeLouise Cullen, Jaimi H Greenslade, Louven Menzies, et al.
International Journal of Cardiology|April 16, 2013
Delta troponin for the early diagnosis of AMI in emergency patients with chest painLouise Cullen, William A Parsonage, Jaimi Greenslade, et al.
Emergency Medicine Australasia : EMA|December 11, 2012
Comparison of early biomarker strategies with the Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for risk stratification of emergency department patients with chest painLouise Cullen, William A Parsonage, Jaimi Greenslade, et al.
The American Journal of Emergency Medicine|May 25, 2013
Validation of the Vancouver Chest Pain Rule using troponin as the only biomarker: a prospective cohort studyJaimi H Greenslade, Louise Cullen, Martin Than, et al.
Heart (British Cardiac Society)|January 6, 2016
Sex-specific versus overall cut points for a high sensitivity troponin I assay in predicting 1-year outcomes in emergency patients presenting with chest painLouise Cullen, Jaimi H Greenslade, Edward W Carlton, et al.
Heart, Lung & Circulation|May 21, 2013
Comparison of three risk stratification rules for predicting patients with acute coronary syndrome presenting to an Australian emergency departmentLouise Cullen, Jaimi Greenslade, Christopher J Hammett, et al.
The American Journal of Emergency Medicine|November 19, 2013
The new Vancouver Chest Pain Rule using troponin as the only biomarker: an external validation studyLouise Cullen, Jaimi H Greenslade, Martin Than, et al.
The Medical Journal of Australia|February 18, 2014
Validation of an accelerated high-sensitivity troponin T assay protocol in an Australian cohort with chest painWilliam A Parsonage, Jaimi H Greenslade, Christopher J Hammett, et al.
Heart, Lung & Circulation|July 1, 2020
CSANZ Position Statement on the Evaluation of Patients Presenting With Suspected Acute Coronary Syndromes During the COVID-19 PandemicWilliam A Parsonage, Louise Cullen, David Brieger, et al.
Pageof 7